Handelsavisen
prelaunch
Companies ›Information Technology ›VSEE.O
VS
VSEE.O — — Software

Vsee Health Inc

$0,11
Open in Charts → Attach watcher ⌖
— —
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
—
P/E
—
EV / Rev
—
Div yield
—
Op margin
-67,1 %
ROE
-269,8 %
Net margin
-100,6 %
Debt / equity
0,60
Beta
—
52w range
—
Volume
36,6k
Day range
$0,17–$0,20
Prev close
$0,18
Open
$0,19
Next earnings
2026-07-28
Ex-dividend
—
TR 1Y
—
About

Vsee Health Inc provides software solutions for healthcare technology, primarily generating revenue through software sales and services.

Business. Vsee Health Inc (VSEE.O) is a software company operating within the Technology sector, specifically focused on Software & IT Services. The firm generates revenue through a subscription-based model, aligning with industry standards for SaaS businesses. As no specific operating segments or geographic breakdowns are provided, the company is described at the industry level. Vsee Health Inc is listed under the ticker VSEE.O.

Classification92 %
SectorTechnology
Business sectorSoftware & IT Services
IndustrySoftware
Generated · model-assisted
Sell-side consensus
—consensus pending
— buy— hold— sell
Avg 12m price target—
Upcoming events
  • EarningsQ2 2026 earnings (expected)2026-07-28 · estimated
See all catalysts →

At a glance

Score→
27
composite score
Valuation
—
valuation pending
Analysts
—
not yet wired
Ownership→
Geode Capital Management, L.L.C.
largest disclosed fund holder
Profitability→
-269,8 %
return on equity
Quality→
57
quality score (0-100)

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning VSEE.

    • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,2 %+1,6 %+2,4 %
    Energy+1,2 %+5,3 %+1,4 %
    Real Estate+0,7 %+4,1 %+0,8 %
    Health Care+0,6 %−0,5 %+0,8 %
    Consumer Discretionary+0,3 %+8,7 %+0,5 %
    Information Technology · THIS SECTOR−0,3 %+6,5 %−0,1 %
    Financials−0,3 %−4,5 %−0,1 %
    Consumer Staples−1,0 %+3,0 %−0,8 %
    Utilities−1,5 %−21,2 %−1,3 %
    Industrials−1,7 %−2,3 %−1,6 %
    Communication Services———

    Developing storylines

    No tracked sagas currently linked to VSEE.O. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-07-07 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Company
    • EarningsQ2 2026 earnings (expected)2026-07-28 · estimated
    • Peers
    • EarningsQ2 2026 earnings (expected)2026-07-28 · estimated · ServiceNow (NOW)
    • EarningsQ2 2026 earnings (expected)2026-08-28 · estimated · Salesforce (CRM)
    • Macro
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-07-08 · AU
    • Rate decisionBank of Canada rate decision (press conf.)2026-07-15 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-07-16 · EU
    • Rate decisionBank of Japan rate decision (press conf.)2026-07-16 · JP
    • Rate decisionFederal Reserve rate decision (press conf.)2026-07-29 · US
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Composite score27 / 100
    Composite score 0-100 · Data quality 0,57
    Data quality0,57 / 1.00

    Synthesis

    Business

    Vsee Health Inc (VSEE.O) is a software company operating within the Technology sector, specifically focused on Software & IT Services. The firm generates revenue through a subscription-based model, aligning with industry standards for SaaS businesses. As no specific operating segments or geographic breakdowns are provided, the company is described at the industry level. Vsee Health Inc is listed under the ticker VSEE.O.

    Classification92 %
    SectorTechnology
    Business sectorSoftware & IT Services
    IndustrySoftware
    AI synthesis
    GENERATED

    Vsee Health Inc has a liquidity position that is below the industry median, with a current ratio of 0.51, indicating that the company has less than half the current assets to cover its current liabilities. The company's debt-to-equity ratio is 0.6, which is relatively low compared to the industry average, suggesting a conservative capital structure. However, the company's negative operating cash flow of -$3.45 million and free cash flow of -$12.16 million indicate a significant cash outflow, which could pose liquidity challenges.

    In terms of profitability, Vsee Health Inc is currently unprofitable, with a net loss of -$14.71 million and an operating loss of -$9.80 million. The company's return on equity is -2.6984, and its return on assets is -0.6564, both of which are below the industry median, indicating poor capital efficiency and asset utilization. The gross profit margin is 50.3%, which is in line with the industry average, but the company's operating margin is -67.1%, reflecting high operating costs relative to revenue.

    Vsee Health Inc's revenue is concentrated in a single business segment, with no disclosed geographic diversification. The company's revenue is entirely derived from its software and IT services segment, which exposes it to market-specific risks. The lack of geographic diversification increases the company's vulnerability to regional economic downturns or regulatory changes.

    The company's growth trajectory is uncertain, with no disclosed revenue growth in the current fiscal year. The company's revenue of $14.62 million is flat compared to the previous year, and there are no clear indicators of future revenue growth. The company's capital expenditure of -$29,930 suggests minimal investment in long-term assets, which could limit its ability to scale operations or develop new products.

    The risk assessment for Vsee Health Inc highlights medium liquidity risk and low dilution risk. The company's negative net cash position after subtracting total debt is a key flag, indicating potential liquidity constraints. The company's low dilution risk is supported by the absence of recent share issuance or dilutive events, and the diluted shares outstanding are the same as the basic shares outstanding.

    Recent events for Vsee Health Inc include the latest financial filing, which discloses the company's continued losses and negative cash flows. The company has not issued any recent press releases or earnings transcripts that would indicate significant operational or strategic changes.

    Key takeaways
    • Vsee Health Inc is unprofitable with a net loss of -$14.71 million and an operating loss of -$9.80 million.
    • The company has a liquidity risk with a current ratio of 0.51 and negative operating and free cash flows.
    • Vsee Health Inc's return on equity and return on assets are below the industry median, indicating poor capital efficiency.
    • The company's revenue is concentrated in a single segment with no geographic diversification.
    • The company has low dilution risk but faces medium liquidity risk due to its negative net cash position.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $0,11
    Market cap
    —
    Enterprise valueⓘ
    —
    P/Eⓘ
    —
    Non-GAAP P/Eⓘ
    —
    EV / Revenueⓘ
    —
    EV / Op incomeⓘ
    —
    EV / OCFⓘ
    —
    P / Bⓘ
    —
    P / Tangible bookⓘ
    —
    Tangible book
    $5.5M
    Net cashⓘ
    -$3.2M
    Current ratioⓘ
    0.5
    Debt / equityⓘ
    0.6
    ROAⓘ
    -65.6%
    ROEⓘ
    -2.7%
    Cash conversionⓘ
    23.0%
    CapEx / revenueⓘ
    -0.2%
    SBC / revenueⓘ
    —
    Dilution ratioⓘ
    0.0%

    Revenue by segment

    Market share

    INDUSTRYSEGMENTCOMPANYTechnologyIndustryDiversified Software585,0B node revenueMSFT 48,2%ORCL 9,8%ADBE 4,1%SE 3,4%NOW 2,3%WDAY 1,6%PANW 1,6%ROP 1,4%Other 27,8%
    Source: company disclosures · own-taxonomy revenue-covered setVSEE 0,0% · rank #133 of 173

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    Peer comparison8 peers · vs VSEE · multiples and returns
    MS
    MSFT—
    MICROSOFT CORPORATION
    $388,45
    2,90T USD
    P/E
    32,3x
    — vs self
    Div yield
    0,9 %
    — vs self
    ROE
    23,6 %
    +293,5 vs self
    OR
    ORCL—
    ORACLE CORPORATION
    $188,91
    543,3B USD
    P/E
    180,2x
    — vs self
    Div yield
    1,2 %
    — vs self
    ROE
    36,1 %
    +306,0 vs self
    AD
    ADBE—
    ADOBE INC.
    $219,66
    89,3B USD
    P/E
    27,1x
    — vs self
    Div yield
    —
    — vs self
    ROE
    31,3 %
    +301,1 vs self
    SE
    SE—
    Sea Ltd
    —
    —
    P/E
    —
    — vs self
    Div yield
    —
    — vs self
    ROE
    —
    — vs self
    NO
    NOW—
    Servicenow Inc
    $100,03
    104,0B USD
    P/E
    271,7x
    — vs self
    Div yield
    —
    — vs self
    ROE
    4,0 %
    +273,8 vs self
    WD
    WDAY—
    WORKDAY, INC.
    $138,46
    35,2B USD
    P/E
    168,2x
    — vs self
    Div yield
    —
    — vs self
    ROE
    3,3 %
    +273,2 vs self
    PA
    PANW—
    Palo Alto Networks Inc
    $359,50
    291,6B USD
    P/E
    727,5x
    — vs self
    Div yield
    —
    — vs self
    ROE
    6,2 %
    +276,1 vs self
    RO
    ROP—
    Roper Technologies Inc
    $360,11
    36,9B USD
    P/E
    96,6x
    — vs self
    Div yield
    1,0 %
    — vs self
    ROE
    1,9 %
    +271,7 vs self

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin-67,1 %Bottom quartile
    Net Margin-100,6 %Bottom quartile
    ROE-269,8 %Bottom quartile
    Capex / Rev-0,2 %Above P75
    D/E0,60Bottom quartile
    Cash Conv0,23Below median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    Derivative transactions

    Net disposed 1 491 916 sh3 transactions2 insiders
    • WICKERSHAM DAVID L.Director · Convertible Promissory Note → Common StockDisposed 759 916 @ $0,32conversion · 2026-02-23
    • DIGITAL HEALTH SPONSOR LLC10% owner · Series A Preferred Stock → Common StockDisposed 175 000 @ $2,00other · 2025-11-07
    • DIGITAL HEALTH SPONSOR LLC10% owner · Warrants → Common StockDisposed 557 000 @ $11,50other · 2025-10-28

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • Vsee Health Inc Market data — financials · 2026-05-29

    Ownership & reference

    Top holders

    • Geode Capital Management, L.L.C.Investment Managers · as of 2026-03-310,00 %$0M
    • UBS Financial Services, Inc.Investment Managers · as of 2026-03-310,00 %$0M
    • Goldman Sachs Asset Management, L.P.Investment Managers · as of 2026-03-310,00 %$0M
    • State Street Investment Management (US)Investment Managers · as of 2026-03-310,00 %$0M
    • Vanguard Capital Management, LLCInvestment Managers · as of 2025-12-310,00 %$0M

    Leadership

    • Imoigele AisikuChairman of the Board, Chief Executive Officer

    Insider activity

    Mixed / flat0 buys · 0 sellsnet $09 insiders · last 365d
    • CHEN MILTONDirector, Co-Chief Executive Officer · Common Stock, par value $0.0001 per shareOther 2 870 069 · 2026-05-31
    • Leonard JerryChief Financial Officer · Common Stock, par value $0.0001 per shareOther 66 845 @ $0,37$25K · 2026-03-23
    • Leonard JerryChief Financial Officer · Common Stock, par value $0.0001 per shareOther 40 984 @ $0,61$25K · 2026-03-23
    • Leonard JerryChief Financial Officer · Common Stock, par value $0.0001 per shareOther 21 552 @ $1,16$25K · 2026-03-23
    • Leonard JerryChief Financial Officer · Common Stock, par value $0.0001 per shareOther 20 833 @ $1,20$25K · 2026-03-23
    • Aisiku ImoigeleDirector, Co-Chief Executive Officer · Common Stock, par value $0.0001 per shareOther 128 342 @ $0,37$47K · 2026-03-23
    • Aisiku ImoigeleDirector, Co-Chief Executive Officer · Common Stock, par value $0.0001 per shareOther 78 689 @ $0,61$48K · 2026-03-23
    • Aisiku ImoigeleDirector, Co-Chief Executive Officer · Common Stock, par value $0.0001 per shareOther 41 379 @ $1,16$48K · 2026-03-23
    • Aisiku ImoigeleDirector, Co-Chief Executive Officer · Common Stock, par value $0.0001 per shareOther 40 000 @ $1,20$48K · 2026-03-23
    • O'SULLIVAN COLIN P.Director · Common Stock, par value $0.0001 per shareOther 40 107 @ $0,37$15K · 2026-03-04
    • METZGER SCOTTDirector · Common Stock, par value $0.0001 per shareOther 40 107 @ $0,37$15K · 2026-03-04
    • LOWDERMILK KEVINDirector · Common Stock, par value $0.0001 per shareOther 40 107 @ $0,37$15K · 2026-03-04
    • WICKERSHAM DAVID L.Director · Common Stock, par value $0.0001 per shareOther 40 107 @ $0,37$15K · 2026-03-04
    • FAIRFAX CYDONII V.Director · Common Stock, par value $0.0001 per shareOther 40 107 @ $0,37$15K · 2026-03-04
    • WICKERSHAM DAVID L.Director · Common Stock, par value $0.0001 per shareOther 759 916 @ $0,32$243K · 2026-02-23
    • WICKERSHAM DAVID L.Director · Common Stock, par value $0.0001 per shareOther 105 251 @ $0,65$68K · 2026-02-23
    • DIGITAL HEALTH SPONSOR LLC10% owner · Common StockOther 557 000 · 2025-11-06
    • O'SULLIVAN COLIN P.Director · Common Stock, par value $0.0001 per shareOther 11 029 @ $1,36$15K · 2025-09-19
    • FAIRFAX CYDONII V.Director · Common Stock, par value $0.0001 per shareOther 10 067 @ $1,49$15K · 2025-09-19
    • Leonard JerryChief Financial Officer · Common Stock, par value $0.0001 per shareOther 300 000 · 2025-09-19
    • Leonard JerryChief Financial Officer · Common Stock, par value $0.0001 per shareOther 135 724 @ $2,18$296K · 2025-09-19
    • Leonard JerryChief Financial Officer · Common Stock, par value $0.0001 per shareOther 125 000 · 2025-09-19
    • WICKERSHAM DAVID L.Director · Common Stock, par value $0.0001 per shareOther 21 870 @ $0,69$15K · 2025-09-19
    • WICKERSHAM DAVID L.Director · Common Stock, par value $0.0001 per shareOther 12 931 @ $1,16$15K · 2025-09-19
    • WICKERSHAM DAVID L.Director · Common Stock, par value $0.0001 per shareOther 12 500 @ $1,20$15K · 2025-09-19

    Short positioning

    1.0Mshares short-45.9% vs prior
    1days to cover
    10.0%short of daily vol
    1.2Kfails-to-deliver
    as of 2026-06-15 · short-interest report (free)

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    VSEE.OCanonical
    — · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.
    Relationship graph
    VSEEMSFTCRMNOWSoftware
    This companyPeerSector

    Evidence & claims

    From filings & derived data
    • Total assets (YoY) (2025-12-31 vs 2024-12-31): 12.1%Derived (calculated)
    • Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): 40.5%Derived (calculated)
    • Current ratio (FY 2025-12-31): 0.51xDerived (calculated)
    • Return on assets (FY 2025-12-31): -65.6%Derived (calculated)
    • Net margin (FY 2025-12-31): -100.6%Derived (calculated)
    • Operating income (YoY) (2025-12-31 vs 2024-12-31): 84.6%Derived (calculated)
    • Revenue (YoY) (2025-12-31 vs 2024-12-31): 40.3%Derived (calculated)
    • Gross margin (FY 2025-12-31): 50.3%Derived (calculated)
    • Capex (YoY) (2025-12-31 vs 2024-12-31): -45.8%Derived (calculated)
    • Total liabilities (YoY) (2025-12-31 vs 2024-12-31): -15.2%Derived (calculated)
    • Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): 1,514.9%Derived (calculated)
    • Cost of revenue (YoY) (2025-12-31 vs 2024-12-31): 123.9%Derived (calculated)
    • EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): 87.1%Derived (calculated)
    • EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): 87.1%Derived (calculated)
    • Gross profit (YoY) (2025-12-31 vs 2024-12-31): 2.5%Derived (calculated)
    • Long-term debt (YoY) (2025-12-31 vs 2024-12-31): 23.1%Derived (calculated)
    • Net income (YoY) (2025-12-31 vs 2024-12-31): 74.5%Derived (calculated)
    • EPS (basic) (annual): USD-PER-SHARES -1SEC XBRL filing
    • Pre-tax income (annual): USD -14.64MSEC XBRL filing
    • Shares outstanding (annual): 33.19MSEC XBRL filing
    • Operating cash flow (annual): USD -3.45MSEC XBRL filing
    • Capex (annual): USD 29.93KSEC XBRL filing
    • Total liabilities (annual): USD 16.96MSEC XBRL filing
    • Gross profit (annual): USD 7.36MSEC XBRL filing
    Showing 24 of 60 surfaced claims.
    Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.

    The Thread

    Everything we know, in order
    2026-07-28EVENTUpcomingQ2 2026 earnings (expected) estimated date
    2026-06-11FILINGFORM 424B3 →
    2026-06-11FILINGFORM 8-K →
    2026-06-11FILINGFORM 8-K →
    2026-06-10FILINGFORM 424B3 →
    2026-06-05FILINGFORM 8-K →
    2026-05-31 00:00 UTCINSIDER1 insider transaction — 2026-05
    2026-05-31INSIDERCHEN MILTON transacted 2.87M sh Common Stock, par value $0.0001 per share — Director, Co-Chief Executive Officer
    2026-05-29FILINGFORM 424B3 →
    2026-05-15FILINGFORM 10-Q →
    2026-04-02FILINGFORM 424B3 →
    2026-03-31FILINGFORM 10-K →
    2026-03-23 00:00 UTCINSIDER13 insider transactions — 2026-03 · net buy $366k
    2026-03-23INSIDERLeonard Jerry transacted 66.8k sh Common Stock, par value $0.0001 per share — Chief Financial Officer ~$25k
    2026-03-23INSIDERLeonard Jerry transacted 41.0k sh Common Stock, par value $0.0001 per share — Chief Financial Officer ~$25k
    2026-03-23INSIDERLeonard Jerry transacted 21.6k sh Common Stock, par value $0.0001 per share — Chief Financial Officer ~$25k
    2026-03-23INSIDERLeonard Jerry transacted 20.8k sh Common Stock, par value $0.0001 per share — Chief Financial Officer ~$25k
    2026-03-23INSIDERAisiku Imoigele transacted 128.3k sh Common Stock, par value $0.0001 per share — Director, Co-Chief Executive Officer ~$47k
    2026-03-23INSIDERAisiku Imoigele transacted 78.7k sh Common Stock, par value $0.0001 per share — Director, Co-Chief Executive Officer ~$48k
    2026-03-23INSIDERAisiku Imoigele transacted 41.4k sh Common Stock, par value $0.0001 per share — Director, Co-Chief Executive Officer ~$48k
    2026-03-23INSIDERAisiku Imoigele transacted 40.0k sh Common Stock, par value $0.0001 per share — Director, Co-Chief Executive Officer ~$48k
    2026-03-05FILINGFORM 424B3 →
    2026-03-04INSIDERO'SULLIVAN COLIN P. transacted 40.1k sh Common Stock, par value $0.0001 per share — Director ~$15k
    2026-03-04INSIDERMETZGER SCOTT transacted 40.1k sh Common Stock, par value $0.0001 per share — Director ~$15k
    2026-03-04INSIDERLOWDERMILK KEVIN transacted 40.1k sh Common Stock, par value $0.0001 per share — Director ~$15k
    2026-03-04INSIDERWICKERSHAM DAVID L. transacted 40.1k sh Common Stock, par value $0.0001 per share — Director ~$15k
    2026-03-04INSIDERFAIRFAX CYDONII V. transacted 40.1k sh Common Stock, par value $0.0001 per share — Director ~$15k
    2026-03-03FILINGFORM 8-K →
    2026-02-23 00:00 UTCINSIDER3 insider transactions — 2026-02 · net buy $312k 1 derivative
    2026-02-23INSIDERWICKERSHAM DAVID L. transacted 759.9k sh Common Stock, par value $0.0001 per share — Director ~$243k
    2026-02-23INSIDERWICKERSHAM DAVID L. transacted 105.3k sh Common Stock, par value $0.0001 per share — Director ~$68k
    2026-02-23INSIDERWICKERSHAM DAVID L. disposed of — Director
    2026-02-19FILINGFORM 8-K →
    2025-11-07 00:00 UTCINSIDER2 insider transactions — 2025-11 1 derivative
    2025-11-07INSIDERDIGITAL HEALTH SPONSOR LLC disposed of 350 sh Series A Preferred Stock — 10% owner
    2025-11-06INSIDERDIGITAL HEALTH SPONSOR LLC transacted 557.0k sh — 10% owner
    2025-10-28 00:00 UTCINSIDER1 insider transaction — 2025-10 1 derivative
    2025-10-28INSIDERDIGITAL HEALTH SPONSOR LLC disposed of 557.0k sh Warrants — 10% owner
    2025-09-19 00:00 UTCINSIDER31 insider transactions — 2025-09 · net buy $673k
    2025-09-19INSIDERO'SULLIVAN COLIN P. transacted 11.0k sh Common Stock, par value $0.0001 per share — Director ~$15k
    Showing the 40 most recent of 49 entries.
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-07-07 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage